Close Menu

NEW YORK (GenomeWeb) – Swiss informatics firm Genedata and Intellicyt today announced an alliance to work on cell-based screening in drug discovery. The firms will integrate Genedata's Screener software with IntelliCyt's iQue Screener system.

The alliance will bring Genedata's highly-scalable data analytics to IntelliCyt's high-throughput flow cytometry capabilities. The iQue Screener can analyze more than 10,000 cells or beads per second, the firm said in a statement, an order of magnitude increase over plate-based systems, with up to 15 parameters per cell.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.